Astrocytes may play a protective role in Parkinson’s disease, slowing alpha-synuclein accumulation in neurons, according to a study published in The Journal of Neuroscience.
Nathan Shlobin, a second-year medical student, was the first author of a study recently published in the Journal of Neurosurgery, which identified through systematic review potential risk factors for spinal cord ischemia related to anterior thoracolumbar surgery.
A newly discovered function of an epigenetic regulator could be a key to new cancer treatments, according to a new study published in Genes and Development.
A novel drug may improve the efficacy of corticosteroid treatment for patients with Duchenne muscular dystrophy and overall quality of life, according to a recent clinical trial.
The three-year grant from the Centers for Disease Control and Prevention will fund the first-ever study looking at how sibling relationships influence firearm involvement.
A brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma, according to a Northwestern Medicine trial.
A multi-institution team of investigators led by Northwestern Medicine scientists has received an $8 million grant for the identification of novel biological targets to develop non-hormonal contraceptives for women in developing countries.
A new three-dimensional imaging technique invented by Northwestern scientists greatly improves the visibility of brain tumors in magnetic resonance imaging scans.
Tanya Simuni, MD, director of the Parkinson’s Disease and Movement Disorders Center, has received a multimillion-dollar grant from The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression for use in clinical trials for novel therapies.
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.